MOH

Rating neutralTentativeAI MemoPost-earnings T+3

Molina Healthcare

As of 2026-10-26/Post-earnings T+3/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-26 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

peer set is too generic or lacks enough direct operating comparators

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Q3 beat met a weaker forward outlook • 2026-10-23

Base target: $215 / p=50% prob

Biggest risk

Adjusted Q3 earnings fell sharply year over year, membership declined, and the Florida ramp burdens Q4. Delayed Georgia and Texas starts reduced preliminary 2027 premium guidance, according to the earnings-call transcript. Post-print target actions were mixed: Benzinga lists October 23 raises from UBS, Morgan Stanley, and RBC, but a Barclays cut; Jefferies raised its target to $220 while retaining Hold.

Invalidation

Break below $160 or thesis failure.

What would change my mind?

The modest Q3 consensus beat, reaffirmed 2026 guidance, and stronger draft Medicaid rates support a possible earnings recovery if medical-cost trend stabilizes. This is a conditional case, not a confirmed margin inflection [#8-K-2026-10-21] company earnings exhibit.

Research note

Recommendation

neutral

Confidence

medium

As of

2026-10-26

Base target

$215

p=50%

Bull target

$260

p=25%

Bear target

$160

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Florida Medicaid contract tests fourth-quarter earnings
2027 Medicaid rate cycle could restore margins
The modest Q3 consensus beat, reaffirmed 2026 guidance, and stronger draft Medicaid rates support a possible earnings recovery if medical-cost trend stabilizes.

BearKey bullets

Consolidated Q3 medical cost ratio rose to 92.9% from 92.6% a year earlier, leaving little margin for further cost pressure [#8-K-2026-10-21] company earnings exhibit.
Draft 2027 rate increases may not translate into better margins if utilization, acuity, or disenrollment develops unfavorably.
Ending membership fell to 4.862 million from 5.628 million a year earlier; lower Medicaid and Marketplace membership reduced premium revenue company earnings exhibit.

WatchKey bullets

Q3 beat met a weaker forward outlook

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $215 (p=50%)

Target spread vs base: +21% / -26%

Scenario probabilities

Bull Target: $260 (p=25%)Base Target: $215 (p=50%)Bear Target: $160 (p=25%)

Commentary

Tone remains mixed despite the Q3 beat: the packet's October 23 anchor is $209.15, and Benzinga reports a 3.46% decline that day. The earnings-call coverage also reports an initial post-release premarket decline, linking concern to the softer 2027 outlook and Florida costs. Analyst target changes are mixed, and the packet supplies no usable social, options, short-interest, or employee measures; the zero placeholders above do not imply neutral readings.

As of 2026-10-26 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Florida Medicaid contract tests fourth-quarter earnings
2027 Medicaid rate cycle could restore margins

Scenarios

Bull Target (Scenario probability)

$260 / p=25% prob

Base Target (Scenario probability)

$215 / p=50% prob

Bear Target (Scenario probability)

$160 / p=25% prob

Analysis 2026-10-26 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

-0.20

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-10-23
Q3 beat met a weaker forward outlook
Molina reported $0.89 adjusted EPS and $11.08 billion revenue, above the $0.79 and $10.86 billion estimates reported by Investing.com. It reaffirmed at least $5.25 of 2026 adjusted EPS, but adjusted EPS fell from $1.84 a year earlier and consolidated medical cost ratio rose to 92.9% [#8-K-2026-10-21] [#SEC-8K-2026-10-21] company earnings exhibit. The earnings-call transcript reports a reduction in preliminary 2027 premium guidance to at least $45 billion from $46.5 billion because Georgia and Texas contract starts were delayed.
Prob 100.00% • Move -3.00% • Priced-in 85.00%

Short-term Catalysts

Next few weeks

Florida Medicaid contract tests fourth-quarter earnings
2026-12-31
Molina's reaffirmed 2026 guidance includes a $1.50-per-share loss from implementing its new Florida Medicaid contract in Q4. The size of that drag makes the ramp an execution test rather than immediate evidence of earnings recovery [#8-K-2026-10-21] company earnings exhibit.
Prob 90% • Move -5% • Priced-in 65%

Long-term Catalysts

Months to a year

2027 Medicaid rate cycle could restore margins
2027-01-01
Management said elevated medical-cost trends may be plateauing and stronger 2027 rate updates could mark the beginning of a Medicaid margin turn [#8-K-2026-10-21] company earnings exhibit. The earnings-call transcript describes approximately 7% draft increases on the known portion of January 1 renewals, but actual margin recovery still depends on medical-cost trend and member mix.
Prob 60% • Move 10% • Priced-in 45%

Risks

Consolidated Q3 medical cost ratio rose to 92.9% from 92.6% a year earlier, leaving little margin for further cost pressure [#8-K-2026-10-21] company earnings exhibit.
Draft 2027 rate increases may not translate into better margins if utilization, acuity, or disenrollment develops unfavorably.
Ending membership fell to 4.862 million from 5.628 million a year earlier; lower Medicaid and Marketplace membership reduced premium revenue company earnings exhibit.
The Florida Medicaid implementation loss and delayed Georgia and Texas starts could defer the earnings recovery company earnings exhibit earnings-call transcript.

Peers

Symbol	Summary
CNC	Closer Medicaid and Marketplace operating comparator than the packet's medical-device candidates, but contract mix and state exposures differ.
ELV	Managed-care comparator for membership, Medicaid rates, and medical-cost ratios; not a precise valuation match.
UNH	Managed-care operating comparator for medical-cost and reimbursement trends, though its scale and business mix differ substantially.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-26

Loading AI feed…

Symbol

Summary

CNC

Closer Medicaid and Marketplace operating comparator than the packet's medical-device candidates, but contract mix and state exposures differ.

ELV

Managed-care comparator for membership, Medicaid rates, and medical-cost ratios; not a precise valuation match.

UNH

Managed-care operating comparator for medical-cost and reimbursement trends, though its scale and business mix differ substantially.